vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Safehold Inc. (SAFE). Click either name above to swap in a different company.
Safehold Inc. is the larger business by last-quarter revenue ($97.9M vs $62.1M, roughly 1.6× Cytek Biosciences, Inc.). Safehold Inc. runs the higher net margin — 28.5% vs -70.9%, a 99.4% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 6.5%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 2.5%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
SAFE Investment Company Limited is a Chinese sovereign wealth fund based in Hong Kong.
CTKB vs SAFE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $97.9M |
| Net Profit | $-44.1M | $27.9M |
| Gross Margin | 52.9% | 98.6% |
| Operating Margin | -9.0% | 27.4% |
| Net Margin | -70.9% | 28.5% |
| Revenue YoY | 8.1% | 6.5% |
| Net Profit YoY | -557.1% | 7.1% |
| EPS (diluted) | — | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $97.9M | ||
| Q3 25 | $52.3M | $96.2M | ||
| Q2 25 | $45.6M | $93.8M | ||
| Q1 25 | $41.5M | $97.7M | ||
| Q4 24 | $57.5M | $91.9M | ||
| Q3 24 | $51.5M | $90.7M | ||
| Q2 24 | $46.6M | $89.9M | ||
| Q1 24 | $44.9M | $93.2M |
| Q4 25 | $-44.1M | $27.9M | ||
| Q3 25 | $-5.5M | $29.3M | ||
| Q2 25 | $-5.6M | $27.9M | ||
| Q1 25 | $-11.4M | $29.4M | ||
| Q4 24 | $9.6M | $26.0M | ||
| Q3 24 | $941.0K | $19.3M | ||
| Q2 24 | $-10.4M | $29.7M | ||
| Q1 24 | $-6.2M | $30.7M |
| Q4 25 | 52.9% | 98.6% | ||
| Q3 25 | 52.7% | 98.5% | ||
| Q2 25 | 52.3% | 99.1% | ||
| Q1 25 | 48.6% | 98.8% | ||
| Q4 24 | 58.5% | 98.8% | ||
| Q3 24 | 56.3% | 98.8% | ||
| Q2 24 | 54.6% | 98.8% | ||
| Q1 24 | 51.3% | 98.8% |
| Q4 25 | -9.0% | 27.4% | ||
| Q3 25 | -17.6% | 25.9% | ||
| Q2 25 | -23.3% | 25.5% | ||
| Q1 25 | -36.1% | 25.9% | ||
| Q4 24 | 5.2% | 24.6% | ||
| Q3 24 | -8.2% | 17.5% | ||
| Q2 24 | -18.3% | 26.7% | ||
| Q1 24 | -23.9% | 26.4% |
| Q4 25 | -70.9% | 28.5% | ||
| Q3 25 | -10.5% | 30.5% | ||
| Q2 25 | -12.2% | 29.8% | ||
| Q1 25 | -27.5% | 30.1% | ||
| Q4 24 | 16.8% | 28.3% | ||
| Q3 24 | 1.8% | 21.3% | ||
| Q2 24 | -22.4% | 33.0% | ||
| Q1 24 | -13.8% | 33.0% |
| Q4 25 | — | $0.38 | ||
| Q3 25 | — | $0.41 | ||
| Q2 25 | — | $0.39 | ||
| Q1 25 | — | $0.41 | ||
| Q4 24 | — | $0.36 | ||
| Q3 24 | — | $0.27 | ||
| Q2 24 | — | $0.42 | ||
| Q1 24 | — | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $21.7M |
| Total DebtLower is stronger | — | $4.6B |
| Stockholders' EquityBook value | $341.7M | $2.4B |
| Total Assets | $461.5M | $7.2B |
| Debt / EquityLower = less leverage | — | 1.90× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $21.7M | ||
| Q3 25 | $93.3M | $12.1M | ||
| Q2 25 | $75.5M | $13.9M | ||
| Q1 25 | $95.3M | $17.3M | ||
| Q4 24 | $98.7M | $8.3M | ||
| Q3 24 | $162.3M | $15.6M | ||
| Q2 24 | $177.9M | $13.4M | ||
| Q1 24 | $168.8M | $11.3M |
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.4B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.2B | ||
| Q1 24 | — | $4.1B |
| Q4 25 | $341.7M | $2.4B | ||
| Q3 25 | $378.6M | $2.4B | ||
| Q2 25 | $377.6M | $2.4B | ||
| Q1 25 | $379.6M | $2.4B | ||
| Q4 24 | $395.7M | $2.3B | ||
| Q3 24 | $385.5M | $2.3B | ||
| Q2 24 | $389.1M | $2.3B | ||
| Q1 24 | $392.6M | $2.3B |
| Q4 25 | $461.5M | $7.2B | ||
| Q3 25 | $494.9M | $7.1B | ||
| Q2 25 | $493.3M | $7.1B | ||
| Q1 25 | $482.6M | $6.9B | ||
| Q4 24 | $499.5M | $6.9B | ||
| Q3 24 | $491.2M | $6.8B | ||
| Q2 24 | $483.7M | $6.8B | ||
| Q1 24 | $492.1M | $6.7B |
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 1.89× | ||
| Q2 25 | — | 1.87× | ||
| Q1 25 | — | 1.85× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.88× | ||
| Q2 24 | — | 1.81× | ||
| Q1 24 | — | 1.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $47.8M |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $47.8M | ||
| Q3 25 | $-3.9M | $-1.4M | ||
| Q2 25 | $108.0K | $28.0M | ||
| Q1 25 | $-125.0K | $8.9M | ||
| Q4 24 | $2.0M | $37.9M | ||
| Q3 24 | $13.2M | $8.3M | ||
| Q2 24 | $6.2M | $24.8M | ||
| Q1 24 | $4.0M | $-3.1M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | — | 1.72× | ||
| Q3 25 | — | -0.05× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | 0.21× | 1.45× | ||
| Q3 24 | 14.05× | 0.43× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | -0.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
SAFE
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $60.3M | 62% |
| Other | $33.7M | 34% |
| Stabilized Properties | $3.8M | 4% |
